Nanomedicine and cancer immunotherapy

Acta Pharmacol Sin. 2020 Jul;41(7):879-880. doi: 10.1038/s41401-020-0426-2. Epub 2020 May 28.

Authors

Hai-Jun Yu¹, Bruno G De Geest²

Affiliations

¹ State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. hjyu@simm.ac.cn.
² Department of Pharmaceutics, Ghent University, Ghent, Belgium. br.degeest@ugent.be.

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Antineoplastic Agents / therapeutic use*
Drug Delivery Systems
Humans
Immunotherapy*
Nanomedicine*
Neoplasms / immunology
Neoplasms / therapy*

Substances

Antineoplastic Agents